Measurable residual disease in chronic lymphocytic leukemia.

MLA

Benintende, Giulia, et al. “Measurable Residual Disease in Chronic Lymphocytic Leukemia.” Frontiers in Oncology, vol. 13, Feb. 2023, p. 1112616. EBSCOhost, https://doi.org/10.3389/fonc.2023.1112616.

APA

Benintende, G., Pozzo, F., Innocenti, I., Autore, F., Fresa, A., D’Arena, G., Gattei, V., & Lurenti, L. (2023). Measurable residual disease in chronic lymphocytic leukemia. Frontiers in Oncology, 13, 1112616. https://doi.org/10.3389/fonc.2023.1112616

Chicago

Benintende, Giulia, Federico Pozzo, Idanna Innocenti, Francesco Autore, Alberto Fresa, Giovanni D’Arena, Valter Gattei, and Luca Lurenti. 2023. “Measurable Residual Disease in Chronic Lymphocytic Leukemia.” Frontiers in Oncology 13 (February): 1112616. doi:10.3389/fonc.2023.1112616.